Advanced search
Showing results 4361 to 4380 on 8966 in total
-
Long-term survival in Hodgkin's disease patients
Pascal Roy, G. Vaughan Hudson, B. Vaughan Hudson, J. Esteve, A.J. Swerdlow
-
Methodological questions in sentinel lymph node analysis in breast cancer patients
Pascal Roy, J.-Y. Bobin, J. Estève
-
[Local control in the management of cancer: a few thoughts].
J Gérard, O Chapet, M Cucherat, P Romestaing, F Mornex, Pascal Roy, J Bobin, V Favrel
-
Reflexions from the experience of the French CLEOPATRE program and concerns about the status of clinical research on small cell lung cancer
Veronique Trillet-Lenoir, J.P. Lotz, A. Le Cesne, Pascal Roy, L. Avallet, A. Edouard
-
Targeted surveillance to assess the prevalence of BSE in high-risk populations in western France and the associated risk factors
E. Morignat, T. Baron, J-L. Vinard, A-G. Biacabe, J-Y. Madec, A. Bencsik, S. Debeer, D. Calavas, T. Garnier, C. Ducrot, Pascal Roy, M. Eliazsewicz
-
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma
C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia, P Arnaud, O Hequet, D Espinouse, G Salles, Pascal Roy, A Eljaafari-Corbin, C Du Manoir-Baumgarten, B Coiffier
-
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group
E. Zucca, A. Conconi, T.I. Mughal, A.H. Sarris, J.F. Seymour, U. Vitolo, R. Klasa, M. Ozsahin, G.M. Mead, M.A. Gianni, S. Cortelazzo, A. Ferreri, A. Ambrosetti, M. Martelli, C. Thieblemont, H.G. Moreno, G. Pinotti, G. Martinelli, R. Mozzana, S. Grisanti, M. Provencio, M. Balzarotti, F. Laveder, G. Tean, V. Callea, Pascal Roy, F. Cavalli, M.K. Gospodarowicz
-
Prevalence of BSE in cattle found dead, euthanased or emergency slaughtered on farms in western France in 2000, 2001 and 2002
Eric Morignat, Didier Calavas, C. Cohen, Christian Ducrot, Pascal Roy
-
Contrast enhancement in atherosclerosis development in a mouse model : in vivo results at 2 Tesla
L. Chaabane, N. Pellet, M.C. Bourdillon, C.D. Mansard, A. Sulaiman, G. Hadour, Françoise Thivolet-Bejui, Pascal Roy, A. Briguet, P. Douek, E. Canet Soulas
-
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Emilie Perrot, Benoit Guibert, Pierre Mulsant, Sonia Blandin, Isabelle Arnaud, Pascal Roy, Laurence Geriniere, Pierre-Jean Souquet
-
Feasibility of pre-operative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial
F. Mornex, Nicolas Girard, J.Y. Scoazec, Nadine Bossard, M. Ychou, D. Smith, J.F. Seitz, P.J. Valette, Pascal Roy, P. Rouanet, M. Ducreux, C. Partensky
-
Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator
F. Descotes, B. Riche, S. Saez, G. de Laroche, J. Datchary, Pascal Roy, P. André, J.-Y. Bobin
-
Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: the French phase IIFFCD 9704-SFRO trial
R. Le Scodan, F. Mornex, C. Partensky, P-J. Valette, M. Ychou, Pascal Roy, J-Y. Scoazec, Catherine Mercier
-
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
R. Le Scodan, F. Mornex, N. Girard, C. Mercier, P.-J. Valette, M. Ychou, F. Bibeau, Pascal Roy, J.-Y. Scoazec, C. Partensky
-
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
Gérald Raverot, Anne Wierinckx, Emmanuelle Dantony, Carole Auger, Guillaume Chapas, Laurent Villeneuve, Thierry Brue, Dominique Figarella-Branger, Pascal Roy, Emmanuel Jouanneau, Michel Jan, Joël Lachuer, Jacqueline Trouillas, Non Renseigné
-
Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial
Nicolas Franck, C. Duboc, C. Sundby, I. Amado, T. Wykes, C. Demily, C. Launay, V. Le Roy, P. Bloch, D. Willard, A. Todd, F. Petitjean, S. Foullu, P. Briant, M. L. Grillon, P. Deppen, H. Verdoux, M. C. Bralet, D. Januel, B. Riche, Pascal Roy, P. Vianin
-
Lack of Correlation of BTNL2 Polymorphism and Cancer Risk in Sarcoidosis. BTNL2 and Cancer Risk in Sarcoidosis
M. Gaillot-Drevon, A. Calender, Jy. Blay, D. Valeyre, D. Israel-Biet, Pascal Roy, Y. Pachero
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Test Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-up Stroke (WAKE-UP)
Götz Thomalla, Jochen Fiebach, Leif Østergaard, Salvador Pedraza, Vincent Thijs, Norbert Nighoghossian, Pascal Roy, Keith Muir, Martin Ebinger, Bastian Cheng, Ivana Galinovic, Tae-Hee Cho, Josep Puig, Florent Boutitie, Claus Simonsen, Matthias Endres, Jens Fiehler, Christian Gerloff
-
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia
M. Di Filippo, Philippe Moulin, Pascal Roy, M. E. Samson-Bouma, S. Collardeau-Frachon, S. Chebel-Dumont, N. Peretti, J. Dumortier, F. Zoulim, T. Fontanges, R. Parini, M. Rigoldi, F. Furlan, G. Mancini, D. Bonnefont-Rousselot, E. Bruckert, J. Schmitz, J. Y. Scoazec, S. Charriere, S. Villar-Fimbel, F. Gottrand, B. Dubern, D. Doummar, Francisca Joly, M. E. Liard-Meillon, A. Lachaux, A. Sassolas
-
Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
Julien Peron, Pascal Roy, K. Ding, W. R. Parulekar, L. Roche, M. Buyse